We have previously shown that CD25 is overexpressed in BP-CML model generated from patient-specific induced pluripotent stem cells (iPSC) and confirmed the increase of its expression during CML progression (21). This evidence concerns the gene IL2RA and chronic myelogenous leukemia, BCR-ABL1 positive.